Novartis: all 3,900 studies
Page 9 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's DiseaseCompletedNCT02180217Phase 3Results posted
- Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis PatientsCompletedNCT02178540Phase 4Results posted
- Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of AgeCompletedNCT02177032Phase 3Results posted
- Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMDCompletedNCT02161575Phase 4Results posted
- OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) PatientsCompletedNCT02161562Phase 3Results posted
- BGJ398 for Patients With Tumors With FGFR Genetic AlterationsTerminatedNCT02160041Phase 2Results posted
- 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing SpondylitisCompletedNCT02159053Phase 3Results posted
- Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.TerminatedNCT02159040Phase 2Results posted
- A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)TerminatedNCT02158936Phase 3Results posted
- Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture SurgeryCompletedNCT02152761Phase 2Results posted
- Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart FailureTerminatedNCT02151383Phase 2Results posted
- Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492CompletedNCT02150213Phase 2Results posted
- PD of VAY736 in Patients With Primary Sjögren's SyndromeCompletedNCT02149420Phase 2Results posted
- A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic AnemiaCompletedNCT02148133Phase 2Results posted
- Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.CompletedNCT02141516Phase 3Results posted
- Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy AdolescentsCompletedNCT02140762Phase 2Results posted
- Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.CompletedNCT02140411Phase 4Results posted
- Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese ChildrenCompletedNCT02139228Phase 3Results posted
- Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing LossCompletedNCT02132130Phase 1/2Results posted
- A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD PatientsCompletedNCT02130024Phase 4Results posted
- Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)CompletedNCT02125877Phase 2Results posted
- Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD PatientsCompletedNCT02125734Phase 4Results posted
- Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 MutationsCompletedNCT02124772Phase 1/2Results posted
- Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1CompletedNCT02122952Phase 1Results posted
- An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary ObjectiveCompletedNCT02116803Phase 2/3Results posted
- Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to NilotinibTerminatedNCT02115386Phase 3Results posted
- REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategyCompletedNCT02115113Phase 3Results posted
- A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid MalignanciesCompletedNCT02108964Phase 1/2Results posted
- Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukaemia (CML) in Chronic Phase Who Are Intolerant to Prior Tyrosine Kinase Inhibitors.TerminatedNCT02108951Phase 3Results posted
- A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)TerminatedNCT02091752Phase 2Results posted
- A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) MyelofibrosisCompletedNCT02087059Phase 3Results posted
- Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive MelanomaCompletedNCT02083354Phase 2Results posted
- Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201TerminatedNCT02075008Phase 2Results posted
- Study of Tolerability and Efficacy of BVS857 in Severe Burn SubjectsTerminatedNCT02074995Phase 2Results posted
- Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type PsoriasisCompletedNCT02074982Phase 3Results posted
- Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast CancerCompletedNCT02069093Phase 2Results posted
- Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) PatientsTerminatedNCT02064868Phase 3Results posted
- Study of Efficacy and Safety of CVAA489 in Hypertensive PatientsCompletedNCT02062645Phase 4Results posted
- Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or AcromegalyCompletedNCT02060383Phase 4Results posted
- Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic FeversCompletedNCT02059291Phase 3Results posted
- Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus InfectionTerminatedNCT02058108Phase 3Results posted
- Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPDCompletedNCT02055352Phase 4Results posted
- Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.CompletedNCT02049450Phase 2Results posted
- Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes MellitusTerminatedNCT02044848Phase 2Results posted
- Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in JapanCompletedNCT02042014Phase 3Results posted
- LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With CrizotinibCompletedNCT02040870Phase 1/2Results posted
- A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.CompletedNCT02040584Phase 3Results posted
- Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the BrainCompletedNCT02039947Phase 2Results posted
- A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple SclerosisTerminatedNCT02038049Phase 2Results posted
- Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.CompletedNCT02038036Phase 3Results posted
- Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersCompletedNCT02034110Phase 2Results posted
- A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.CompletedNCT02034006Phase 3Results posted
- Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment PhaseTerminatedNCT02032173Phase 3Results posted
- Safety and Efficacy of BAF312 in DermatomyositisTerminatedNCT02029274Phase 2Results posted
- Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular AtrophyCompletedNCT02024932Phase 2Results posted
- Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.CompletedNCT02017860Phase 2Results posted
- Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and HumiraCompletedNCT02016105Phase 3Results posted
- Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off CyclesTerminatedNCT02015663Phase 4Results posted
- 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis PatientsCompletedNCT02008916Phase 3Results posted
- Palmoplantar Pustular Psoriasis Efficacy and Safety With SecukinumabCompletedNCT02008890Phase 3Results posted
- Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHFTerminatedNCT02007720Phase 3Results posted
- Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and GlimepirideCompletedNCT02007278Phase 4Results posted
- ACZ885 for the Treatment of Abdominal Aortic AneurysmTerminatedNCT02007252Phase 2Results posted
- Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) PatientsCompletedNCT02002702Phase 2Results posted
- LDE225 for Patients With PTCH1 or SMO Mutated TumorsTerminatedNCT02002689Phase 2Results posted
- Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM PatientsCompletedNCT02002221Phase 4Results posted
- A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related ComplicationsCompletedNCT01998477Phase 3Results posted
- Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD.CompletedNCT01996319Phase 3Results posted
- Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy ToddlersCompletedNCT01994629Phase 2Results posted
- Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)CompletedNCT01992536Phase 2Results posted
- Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years OldCompletedNCT01992107Phase 3Results posted
- Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and OlderCompletedNCT01992094Phase 3Results posted
- 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic ArthritisCompletedNCT01989468Phase 3Results posted
- UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)CompletedNCT01988662Phase 4Results posted
- Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected EyeCompletedNCT01986907Phase 4Results posted
- Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenCompletedNCT01985334Phase 4Results posted
- Safety of Repeat Doses of IV Serelaxin in Subjects With Chronic Heart FailureCompletedNCT01982292Phase 2Results posted
- Study of the Vascular Effects of SerelaxinCompletedNCT01979614Phase 2Results posted
- Cangrelor to Clopidogrel or Prasugrel Transition StudyCompletedNCT01979445Phase 2Results posted
- Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01976338Phase 3Results posted
- Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)CompletedNCT01976312Phase 3Results posted
- A Phase 2 Study of BGJ398 in Patients With Recurrent GBMCompletedNCT01975701Phase 2Results posted
- Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years.CompletedNCT01973218Phase 3Results posted
- Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of MigraineCompletedNCT01973205Phase 3Results posted
- Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)CompletedNCT01972789Phase 4Results posted
- A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076.TerminatedNCT01972776Phase 2Results posted
- Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)CompletedNCT01967550Phase 3Results posted
- Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.CompletedNCT01961609Phase 3Results posted
- Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPDCompletedNCT01959516Phase 4Results posted
- Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent AsthmaCompletedNCT01959412Phase 2Results posted
- Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMDCompletedNCT01958918Phase 4Results posted
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast CancerCompletedNCT01958021Phase 3Results posted
- A Rollover Study to Provide Continued Treatment With EltrombopagCompletedNCT01957176Phase 4Results posted
- Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid TumorsCompletedNCT01956669Phase 2Results posted
- Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)CompletedNCT01952015Phase 3Results posted
- Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)CompletedNCT01950819Phase 4Results posted
- Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMDCompletedNCT01948830Phase 3Results posted
- 16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease PatientsCompletedNCT01948791Phase 4Results posted
- Study of Efficacy and Safety of VAY736 in Patients With Pemphigus VulgarisTerminatedNCT01930175Phase 2Results posted
- Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood TransplantCompletedNCT01930162Phase 2Results posted